Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center, retrospective cohort study.
about
Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center, retrospective cohort study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dose-enhanced combined priming ...... r, retrospective cohort study.
@en
Dose-enhanced combined priming ...... r, retrospective cohort study.
@nl
type
label
Dose-enhanced combined priming ...... r, retrospective cohort study.
@en
Dose-enhanced combined priming ...... r, retrospective cohort study.
@nl
prefLabel
Dose-enhanced combined priming ...... r, retrospective cohort study.
@en
Dose-enhanced combined priming ...... r, retrospective cohort study.
@nl
P2093
P2860
P356
P1476
Dose-enhanced combined priming ...... r, retrospective cohort study.
@en
P2093
Fangxia Wang
Jianli Wang
Liufang Gu
Wanggang Zhang
Xiaorong Ma
Xingmei Cao
P2860
P304
P356
10.2147/OTT.S96427
P407
P577
2016-06-20T00:00:00Z